British Medical Association
British Medical Association
Programme Pilote - Infarctus du myocarde (IDM) Veille documentaire octobre 2012 Indicateurs publiés « Infarctus du myocarde et prévention secondaire » Liste des publications en rapport avec les indicateurs, critères qualité, rapports et analyses des mesures de la qualité Sigle Organisme Titre du document Année URL du document BMA British Medical Association Coronary heart disease: the 2012 http://qualitymeasures.ahrq.gov/c percentage of patients with coronaryontent.aspx?f=rss&id=34459 heart disease with a record in the preceding 15 months that aspirin, an alternative anti-platelet therapy, or an anticoagulant is being taken. BMA British Medical Association 2012Coronary heart disease: the http://qualitymeasures.ahrq.gov/c percentage of patients with coronaryontent.aspx?f=rss&id=34458 heart disease whose last measured total cholesterol (measured in preceding 15 months) is 5 mmol/l or less BMA British Medical Association Coronary heart disease: the 2012 http://qualitymeasures.ahrq.gov/c percentage of patients with coronaryontent.aspx?f=rss&id=34457 heart disease in whom the last blood pressure reading (measured in the preceding 15 months) is 150/90 or less. BMA Coronary heart disease: the practice 2012 http://qualitymeasures.ahrq.gov/c can produce a register of patients withontent.aspx?f=rss&id=34455 coronary heart disease. BMA Coronary heart disease: the 2012 http://qualitymeasures.ahrq.gov/c percentage of patients with coronaryontent.aspx?f=rss&id=34460 heart disease who are currently treated with a beta-blocker. Coronary heart disease: the 2012 http://www.qualitymeasures.ahrq. percentage of patients with coronarygov/content.aspx?id=34462 heart disease who have had influenza immunisation in the preceding 1 September to 31 March. Coronary heart disease: percentage 2012 http://qualitymeasures.ahrq.gov/c of patients with a history ofontent.aspx?f=rss&id=34461 myocardial infarction currently treated with an ACE inhibitor (or ARB if ACE intolerant), aspirin or an alternative anti-platelet therapy, beta-blocker and statin. NHS IC 2012ACE inhibitor therapy for patients withhttps://indicators.ic.nhs.uk/downl myocardial infarctionoad/NCHOD/Specification/Spec_ 09O 607PC 11 V1. df NHS IC 2012Antiplatelet / anti-coagulant therapyhttps://indicators.ic.nhs.uk/downl for patients with coronary heartoad/NCHOD/Specification/Spec_ disease09M_605PC_11_V1.pdf NHS IC Beta blocker therapy for patients with 2012https://indicators.ic.nhs.uk/downl coronary heart diseaseoad/NCHOD/Specification/Spec_ 09N_606PC_11_V1.pdf NHS IC 2012Blood pressure in patients withhttps://indicators.ic.nhs.uk/downl coronary heart diseaseoad/NCHOD/Specification/Spec_ 09K 603PC 11 V1. df NHS IC Body Mass Index 2012https://indicators.ic.nhs.uk/downl /Specification/Sp _ oad/NCHOD ec 02D 310VSP2 09 V1. df NHS IC 2012Cholesterol levels in patients withhttps://indicators.ic.nhs.uk/downl coronary heart diseaseoad/NCHOD/Specification/Spec_ 09L 604PC 11 V1. df NHS IC Diastolic blood pressure 2012https://indicators.ic.nhs.uk/downl oad/NCHOD/Specification/Spec_ _ _ _ pdf 08C 306VSP2 09 V1.
BMA
BMA
British Medical Association
British Medical Association
National Health Service Information Centre
National Health Service Information Centre National Health Service Information Centre
National Health Service Information Centre
National Health Service Information Centre National Health Service Information Centre
National Health Service Information Centre
HAS / Service Programmes Pilotes - Impact clinique / Octobre 2012 1/5